Ketamine for depression has emerged as one of the most discussed breakthroughs in psychiatric care in recent years. For people whose symptoms do not respond to standard antidepressants, ketamine offers a new path that can work much faster than traditional options. This first part of the post explains what treatment-resistant depression looks like, why clinicians are turning to ketamine, and why rapid relief matters for many patients.
Understanding Treatment-Resistant Depression
Treatment-resistant depression, often abbreviated TRD, refers to major depressive disorder that does not improve after adequate trials of two or more antidepressant treatments. Estimates suggest that roughly one in three people with major depression meet this definition. Patients with TRD face prolonged suffering, reduced work and social function, and a higher risk of suicidal thoughts. Traditional antidepressants can take weeks to begin working and do not help everyone. That gap in effective options has driven interest in alternative treatments like ketamine for depression.
Ketamine As An Alternative Treatment
Ketamine started as an anesthetic medicine in the 1960s and has been used safely in operating rooms for decades. In the last 15 years, researchers and clinicians began studying lower doses of ketamine for psychiatric uses. Today, ketamine for depression is offered in controlled clinical settings in several forms, including intravenous infusions and an FDA-approved intranasal formulation of esketamine. Clinicians consider ketamine when patients have not improved with standard therapies or when rapid symptom control is critical.
Take the 3 minute assessment to find your personalized mood support formula.
Support should be specific, not generic.
Learn more about depression and how it affects the brain.
The Promise Of Rapid Relief
One of the most important features driving attention to ketamine for depression is speed. Unlike many antidepressants that need weeks to take effect, ketamine can reduce depressive symptoms within hours to days for some patients. Recent clinical work from 2023 to 2025 has reinforced that ketamine produces fast, often clinically meaningful improvements in people with TRD. Rapid relief can be life-saving for patients with severe symptoms or active suicidal thoughts, and it can open a window for other treatments, such as therapy, to be more effective.
That said, ketamine for depression is not a single, permanent cure. Treatment plans usually require careful evaluation, monitoring, and follow-up. In the next part of this series we will examine the evidence on effectiveness, compare different delivery methods, and explain how ketamine works in the brain.
Efficacy of ketamine for depression
Recent clinical work has moved beyond early signals to more precise estimates of how well ketamine works for people with treatment-resistant depression. Multiple studies now report rapid and substantial symptom reductions. For example, low-dose IV ketamine infusions showed a mean 49.22% reduction in standardized depression scores after eight doses in large samples. Intranasal esketamine has produced marked benefits as well, with some reports noting about 70% improvement in patients evaluated for severe suicidal thinking.
Speed of effect is a defining feature. Many patients report measurable improvement within one to four hours after a single session, and benefits can persist for days to weeks. In difficult-to-treat cases, some programs report remission rates above 50 percent after three IV infusions. These outcomes help explain why clinicians consider ketamine for depression when rapid symptom control is a priority.
Comparing IV ketamine and intranasal esketamine
Choosing between IV ketamine and intranasal esketamine involves trade-offs in logistics, onset, and monitoring needs. The following table summarizes common differences observed in clinical practice and recent studies.
| Feature | IV ketamine | Intranasal esketamine |
|---|---|---|
| Administration | Controlled infusion in clinic | Supervised nasal spray in clinic |
| Typical speed of onset | Often within 1 to 4 hours after first dose | Often after the second dose; somewhat slower initial response |
| Duration of effect | Days to weeks per course; variable between patients | Days to weeks; maintenance dosing is common |
| Side effects | Transient dissociation, blood pressure rise, nausea; usually resolves within an hour | Similar profile but generally milder dissociation; monitoring still required |
Take the 3 minute assessment to find your personalized mood support formula.
Support should be specific, not generic.
Learn more about depression and how it affects the brain.
How ketamine works in the brain
Ketamine for depression acts differently than traditional antidepressants. Rather than targeting monoamine systems directly, ketamine promotes a rapid release of glutamate, which stimulates downstream receptors and intracellular signaling pathways. This cascade encourages synaptogenesis and strengthens neural circuits involved in mood regulation. In some studies, markers of neuroplasticity increase within hours of treatment, which helps explain the quick clinical responses.
Researchers are also studying how intracellular signaling mechanisms might be enhanced to lengthen benefit. Early lab findings suggest that modifying signaling pathways could reduce the need for frequent repeat dosing, but clinical translation is ongoing.
Maintenance, relapse, and expectancy effects
Initial response to ketamine for depression can be dramatic, but sustaining that response remains a challenge. About 30 percent of patients who initially respond may lose that benefit over time without maintenance. Common clinical strategies include scheduled booster infusions or ongoing supervised intranasal dosing. Long-term protocols vary, and decisions are tailored between clinician and patient.
Expectancy and placebo effects also influence outcomes. Some trials have found notable improvements in placebo groups, highlighting the importance of comprehensive care that includes psychological support alongside pharmacologic treatment.
Safety and patient outcomes
Overall, ketamine and esketamine show high short-term response rates in people with severe and suicidal depression when administered in controlled settings. Side effects tend to be transient, often resolving within an hour, and include dissociation, mild increases in blood pressure, and nausea. Long-term safety data remain incomplete, so ongoing monitoring and research are essential.
If you or someone you care for is considering ketamine for depression, discuss candidacy, risks, and follow-up plans with a qualified clinician. Treatment decisions should balance potential rapid benefits against the need for monitoring, maintenance planning, and integrated psychosocial care.
Challenges And Considerations
While ketamine for depression can produce rapid improvements, several practical and clinical issues affect its use. One key challenge is sustaining benefit. Many patients require a clear maintenance plan after the initial course, and strategies vary by clinic. Common options include scheduled booster infusions, transition to intranasal esketamine for maintenance, or integrating regular psychotherapy to prolong gains.
Expectancy effects also shape outcomes. Patients who expect rapid relief may report stronger early benefits, and clinicians should address hope while setting realistic goals. Proper informed consent helps align expectations with likely timelines and possible need for repeated treatments.
Not every patient is an ideal candidate. Considerations include:
- Cardiovascular status. Uncontrolled high blood pressure may rule out in-clinic infusions until managed.
- Substance use history. Active substance misuse can complicate treatment and monitoring.
- Pregnancy and breastfeeding. Limited data means many clinics avoid ketamine for depression in these populations unless benefits clearly outweigh risks.
- Medication interactions. Some psychiatric meds require adjustment or closer observation during treatment.
Access and cost are practical barriers. Ketamine therapy is often delivered in specialized clinics and can be expensive. Insurance coverage differs for IV ketamine versus FDA-approved intranasal esketamine, so verify benefits and out of pocket estimates before starting.
Patient Outcomes And Safety
Short term, most patients experience rapid symptom relief and improvement in suicidal thinking when treatment is given in a monitored setting. Adverse effects tend to be transient and manageable with proper protocols.
Common safety points clinicians monitor:
- Vital signs. Blood pressure and heart rate are checked before, during, and after sessions.
- Acute psychological effects. Dissociation or perceptual changes are common but usually resolve within an hour.
- Functional precautions. Patients should not drive or operate heavy machinery for the remainder of the day after a session.
Long term safety evidence is still evolving. Concerns under study include urinary symptoms and cognitive changes with repeated high dose or unsupervised use. Most clinics use the lowest effective dose and documented protocols to limit cumulative exposure. Ongoing registries and research aim to clarify risks over months to years.
Effective care combines medical monitoring with psychosocial supports. Safety planning is essential for patients with suicidal risk, even when ketamine for depression produces a rapid reduction in distress. Coordinated follow up, psychotherapy, and family communication strengthen longer term outcomes.
How To Approach Treatment
If you are considering ketamine for depression, take these steps to make an informed choice:
- Get a comprehensive psychiatric evaluation that clarifies diagnosis and medical risks.
- Ask the clinic about experience, monitoring protocols, and emergency procedures.
- Request a clear maintenance plan that explains when boosters or transition to esketamine may be used.
- Check cost and insurance coverage for ketamine therapy and any required follow up visits.
- Plan for a support person to accompany you to sessions when advised by the clinic.
Ketamine for depression is a promising tool for people who have not improved with standard therapies. It is not a standalone cure but can create a vital window for recovery if used within a thoughtful, monitored program that includes ongoing follow up and next-step planning.
If you are exploring options, speak with a qualified clinician to review candidacy and next steps. Taking action early and choosing a program with clear protocols increases the chances of safe, meaningful improvement.
Discover what your body needs to support mood and emotional balance.
Small changes in input can create meaningful shifts over time.
Explore more depression-related guides.
and take Cenario quiz here.
Frequently asked questions
Can I Drive After A Ketamine Session?
After ketamine for depression, most clinics advise against driving for the rest of the day because dissociation and slowed reactions may persist. Arrange transportation home and follow your clinic’s specific post treatment instructions.
Will Insurance Cover Ketamine Treatment?
Coverage for ketamine for depression varies. FDA approved intranasal esketamine may be covered under medical benefits in some plans, while IV ketamine infusions are often billed differently and may require prior authorization. Confirm benefits with your insurer before starting treatment.
How Should I Prepare For A Ketamine Infusion?
Prepare by attending a medical evaluation, bringing a list of medications, and arranging a responsible person to drive you home. Your clinic will advise fasting rules if any and explain monitoring during and after ketamine for depression sessions.
Frequently Asked Questions
Can I Drive After A Ketamine Session?
After ketamine for depression, most clinics advise against driving for the rest of the day because dissociation and slowed reactions may persist. Arrange transportation home and follow your clinic’s specific post treatment instructions.
Will Insurance Cover Ketamine Treatment?
Coverage for ketamine for depression varies. FDA approved intranasal esketamine may be covered under medical benefits in some plans, while IV ketamine infusions are often billed differently and may require prior authorization. Confirm benefits with your insurer before starting treatment.
How Should I Prepare For A Ketamine Infusion?
Prepare by attending a medical evaluation, bringing a list of medications, and arranging a responsible person to drive you home. Your clinic will advise fasting rules if any and explain monitoring during and after ketamine for depression sessions.
